tranScrip Announces Appointment of Dr. Rosemarie Delaney as Head of Market Access

tranScrip is delighted to announce the appointment of Dr. Rosemarie Delaney as Head of Market Access. This exciting addition to our leadership team follows our recent appointment of John Ivory as Head of Commercialisation, further reinforcing our commitment to advancing patient access to breakthrough treatments.

Bringing over 25 years of senior industry experience, Rosemarie has held pivotal roles across pharmaceutical, vaccine, and medical device sectors at UK, European, and Global Director levels. Her extensive background includes senior positions at Indivior, Bristol Myers Squibb, Sanofi Pasteur, MSD, and Servier Laboratories, and interim roles at Norgine, Eisai and Pfizer. With deep expertise in Global Market Access Strategy, Pricing and Reimbursement, and Value Proposition Development, Rosemarie is ideally placed to address the evolving needs of our clients and further accelerate the journey of new medicines from development to patient care.

Rosemarie commented on her appointment to tranScrip: “I am thrilled to join tranScrip at such a pivotal time. The opportunity to enhance market access strategies and support the swift delivery of innovative therapies to patients aligns perfectly with my passion and experience. I look forward to working alongside the talented tranScrip team to help our clients navigate the complexities of pricing, reimbursement, and health technology appraisal, ensuring that critical treatment decisions are informed by robust data and strategic insight.”

John Ivory, Head of Commercialisation at tranScrip, added: “Following my recent appointment, I am delighted to welcome Rosemarie to our team. Our clients have increasingly sought guidance beyond regulatory approval—seeking expertise in areas that ensure medicines reach patients as efficiently as possible. Rosemarie’s impressive track record in market access and her strategic acumen will be instrumental in strengthening our commercialisation offering. Together, we are poised to drive forward our mission of enabling clients to maximise the value of their products.”

At tranScrip, our purpose is clear: to expedite the development and commercialisation of products for the benefit of patients worldwide. By integrating Rosemarie’s wealth of expertise with our established capabilities, we are even better positioned to support our clients through every phase of the product lifecycle—from TRANslation to preSCRIPtion.

For more insights into our team members, visit Our People.

About tranScrip
tranScrip is a highly specialist pharmaceutical consultancy providing strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle – from TRANslation to preSCRIPtion. We exist to enable our clients to maximise the value of their products for the benefit of patients worldwide. For more information, please visit www.transcrip-group.com and follow us on LinkedIn.

Media Contact
Ashton Brooke-Thorne
Senior Marketing Manager
ashton.brooke-thorne@transcrip-group.com